June 12, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Summer Meeting Registration is Open!

8 Days Left to Pre-Register

The NRG Oncology 2023 Summer Meeting is open for registration! Join us in celebrating our 10^th anniversary at our Summer Meeting in Philadelphia from Thursday, July 20, 2023 - Saturday, July 22, 2023. Sessions will be held in-person and available via streaming unless noted. Additionally, there will be virtual-only sessions on Monday and Tuesday, July 17-18, 2023. The deadline to pre-register is June 19, 2023. Registrations after that date will incur a $50 late fee.  Click here to Register Today

Join Us At The Barnes

NRG Oncology will host our 10th anniversary at the Barnes Foundation on Friday, July 21, 2023 from 6-8 PM. Transportation will be provided.

Summer Symposium - Rare Tumors: Ideas for Implementation of Novel Concepts. Thursday, July 20, 2023. 8am – 12pm ET. See Flyer

Social Media Workshop

The Social Media Workshop is now being planned as a Virtual-Only session on Monday, July 17, 2023, from 10-11am EDT. The session also will be recorded and posted on the NRG Oncology website after the Summer Meeting. More information will be coming soon!

Social Media Ambassadors wanted for #NRG2023

Apply now to be a #NRG2023 Social Media Ambassador for the NRG Oncology Summer Meeting being held July 20-22, 2023, in Philadelphia! This is the 10^th anniversary celebration of NRG Oncology, so what better way to raise your profile than to be posting on your Twitter and/or Instagram accounts about all things #NRG2023? If interested, please send an e-mail (& please include your Twitter handle) to: communications@nrgoncology.org or send us a DM on Twitter by July 10, 2023.

AMENDMENTS

BRAIN

NRG-BN009: Amendment 1, version date April 6, 2023, and Study Memorandum dated June 12, 2023 (posted on CTSU). The SRS plus HA-WBRT arm of the protocol has been modified to be HA-WBRT alone. Accrual of new patients must be suspended until the IRB of record has reviewed and approved the amendment. Please see the Study Memorandum for more information.

GYNECOLOGIC

NRG-GY020: Amendment 8; version date: May 9, 2023 (posted on CTSU)

HEAD & NECK

RTOG 0920: Amendment 14, version date: May 11, 2023 (posted on CTSU)

FORM UPDATES

BRAIN

NRG-BN009: The Blank Rave Forms document, Data Submission tables (Arm 1A & Arm 2A), and OPEN Eligibility Checklist has been revised. The forms are posted to CTSU. Please begin using these new forms immediately.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BRAIN

NRG-BN003: A patient study web page is available on the NRG website and an updated patient brochure is posted on CTSU.

NRG-BN009: A patient study web page is available on the NRG website and an updated patient brochure, study overview slides, and pathology/correlative science instructions are posted to CTSU.

3. BREAST

NSABP B-43 & NSABP B-47: Protocol Status memorandum (posted on CTSU)

4. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: Patient-Directed Videos are now available on CTSU and YouTube for site research staff to share with patients to encourage enrollment in the NRG-CC005/FORTE study. This resource has been CIRB approved for patient use; be sure to determine if videos need to be submitted to your local IRB according to local guidelines.

5. GYNECOLOGIC 

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY012 and NRG-GY023 – Reminder: BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation. 

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

6. HEAD & NECK

NRG-HN008 - Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday July 12, 2023.

DRUG SAFETY UPDATES

Drug Safety updates have been issued for the following studies:

1. Register Today: Social Determinants of Cancer Care ~ Lessons Learned and Future Directions

Symposium hosted by the NRG Oncology Health Disparities Committee - Research Implementation Special Interest Group

Social determinants of health play a critical role in cancer care delivery and ultimately cancer outcomes. Furthermore, underrepresented patients have a disproportionately greater burden of cancer, with often higher mortality rates across a wide spectrum of cancer types attributable to bearing more advanced stage and aggressive disease as well as difficulties in access to equitable care, particularly among racial and ethnic minorities, older adults, and rural populations. This symposium will address current challenges related to social determinants of health, cancer care delivery and outcomes that includes innovative interventions to address disparities.

This symposium is being held via Zoom on Friday, June 30, 2023, from 2-3:30pm EDT. Please view the flyer here. Click here to register. 

2. Juneteenth Holiday Information

All NRG Oncology Operations Offices and Statistics and Data Management Centers (SDMCs) will be closed on Monday, June 19, 2023, in observance of the Juneteenth holiday. The Biospecimen Banks in Pittsburgh and San Francisco will also be closed on June 19. The Biospecimen Bank in Columbus, the Baylor Serum Bank, and McKesson's Clinical Research Services will be open on June 19. A memo with more information is posted on the CTSU website.

3. ComboMATCH Investigators are Translating Robust Pre-Clinical Evidence for New Anti-Cancer Drug Combinations into a Series of Early-Phase Clinical Trials

Five leading cancer research organizations in the United States are jointly announcing the start of patient enrollment in Molecular Analysis for Combination Therapy Choice (ComboMATCH), a unique, precision medicine initiative to test new combinations of cancer drugs guided by tumor biology. The Alliance for Clinical Trials in Oncology, Children's Oncology Group, ECOG-ACRIN Cancer Research Group, NRG Oncology, and SWOG Cancer Research Network plan to conduct many early-phase treatment trials through this platform in collaboration with the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). NCI is part of the National Institutes of Health. Read the joint NCTN press release.

4. NRG Oncology Awards 11 Fellows for the Early Career & New Investigator Mentored Fellowship Program

NRG Oncology recently selected 11 individuals to be NRG Early Career & New Investigator (ECNI) Fellows on behalf of the organization. Each individual comes with a different area of concentration for their career focus. NRG ECNI Fellows will have the opportunity to be engaged via close mentorship with the ECNI Liaison and Chairs of their assigned NRG disease site committee for the one-year term. Read the article here and learn more about the fellows.

NRG Oncology is pleased to report the scientific article that appeared during the previous week. This publications report includes the link to the article.

JOURNAL ARTICLE

Lee NY, Harris J, Kim J, Garden A, Mechalakos J, Pfister DG, Chan ATC, Hu K, Colevas AD, Frank S, Shenouda G, Bar-Ad V, Waldron JN, Harari PM, Raben A, Torres-Saavedra P, Le QT. Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. JAMA Netw Open. 2023 Jun 1;6(6):e2316094. doi: 10.1001/jamanetworkopen.2023.16094. PMID: 37266942; PMCID: PMC10238946. Read more.

Please note the following upcoming meeting and abstract submission deadlines

UPCOMING MEETINGS

Western Association of Gynecologic Oncologists (WAGO); Jun 14-17, 2023; Monterey, CA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; LBA Jul 12, 2023

ESMO World Congress on Gastrointestinal Cancer; Jun 28-Jul 1, 2023; Barcelona, Spain; LBA Jun 15, 2023

European Society of Gynaecological Oncology (ESGO); Sep 28-Oct 1, 2023; Istanbul, Turkey; LBA Aug 7, 2023

European Society for Medical Oncology (ESMO) Congress; Oct 20-24, 2023; Madrid, Spain; LBA Sep 14, 2023, 9pm CEST

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2023; Seoul, South Korea; Abstract & Film; TiP LBA, Aug 21, 2023

International Society for Quality-of-Life Research (ISOQOL); Oct 18-21, 2023; Calgary, AB Canada; LBA Jul 7, 2023

San Antonio Breast Cancer Symposium (SABCS); Dec 5-9, 2023; due to publications Jun 12, 2023; meeting submission deadline Jul 10, 2023; LBA Sep 30, 2023, 11:59 PM CT.



Society for NeuroOncology (SNO); Nov 15-19, 2023; Vancouver, Canada; LBA Sep 4, 2023, 5:00 PM EDT.